RetractedArticleBioengineered2022

miR-647 inhibits hepatocellular carcinoma cell progression by targeting protein tyrosine phosphatase receptor type F.

Xiangyang Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.